DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations. Read more about DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations.
Abstract 2497: Glioma-induced neuronal remodeling promotes regional immunosuppression. Read more about Abstract 2497: Glioma-induced neuronal remodeling promotes regional immunosuppression.
Abstract 1509: Longitudinal profiling of high-risk pediatric malignancies using a multiomics approach. Read more about Abstract 1509: Longitudinal profiling of high-risk pediatric malignancies using a multiomics approach.
Abstract 1161: Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory function. Read more about Abstract 1161: Primary and metastatic tumors exhibit systems-level differences in dependence on mitochondrial respiratory function.
Abstract 1931: Racialized economic segregation and late-stage colorectal cancer in the United States, 2009-2017. Read more about Abstract 1931: Racialized economic segregation and late-stage colorectal cancer in the United States, 2009-2017.
Abstract 5711: Blood-based early detection of non-small cell lung cancer using orphan noncoding RNAs. Read more about Abstract 5711: Blood-based early detection of non-small cell lung cancer using orphan noncoding RNAs.
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer. Read more about Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.
Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer. Read more about Correction: Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.
Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival. Read more about Abstract P6-08-09: Self-identified race and Area Deprivation Index in patients with invasive lobular carcinoma of the breast: associations with tumor characteristics and event free survival.
Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP). Read more about Abstract P3-09-01: Characterization of residual disease after neoadjuvant selective estrogen receptor degrader (SERD) therapy using tumor organoids in the I-SPY Endocrine Optimization Protocol (EOP).
